In particular, a grow incidence of atrial fibrillation, ventricular arrhythmias and sudden death with BTK inhibitors was identified in the literature (Lampson et al., 2017; Salem et al., 2019; Christensen et al., 2022). This evidence concerns the gene BTK and Ventricular arrhythmia.